SUMMARY The effects of loperamide on net solute and water absorption, and prostaglandin E2 (PGE2) and cholera toxin-induced secretion were studied in the rat jejunum using an in vivo steady-state perfusion technique. Loperamide stimulated absorption of fluid, electrolytes, and glucose and reversed PGE, and cholera toxin-induced secretion to absorption; this opiate analogue had no effect on cholera toxin stimulation of adenylate cyclase activity or the rise of tissue cyclic AMP (cAMP) concentrations. The opiate antagonist, naloxone, reduced the antisecretory effects of loperamide without affecting tissue levels of cAMP. These results indicate that loperamide inhibits PGE, and cholera toxin-induced secretion, and that this phenomenon is independent of any direct effect that cholera toxin has on the adenylate cyclase system. The action of naloxone suggests, but does not prove, that loperamide exerts its effect via opiate receptors.
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Loperamide, an opiate analogue, is a widely used anti-diarrhoeal agent and, until recently, its effects were attrilbuted to an inhibitory action on smooth muscle tone and peristalsis mediated via both cholinergic and non-cholinergic systems.1'-Karim and Adaikan,4 however, observed that loperamide modified prostaglandin E, (PGE,) induced secretion of fluid in the rat intestinal tract and they postulated that its anti-diarrhoeal action might be related not only to an effect on intestinal motility, but also on secretory processes.
We have recently been impressed by the beneficial effects of very large oral doses of loperamide (up loop was returned to the abdominal cavity. The solutions were infused continuously at 0.46 ml/ min (Harvard 975 syringe pump), and were warmed by passage through the inlet catheter in a water bath at 370C. After an equilibration period of 30 minutes, three consecutive 10 minute collections of effluent were obtained. The perfusate contained (mmol/l) NaCl (130), KCI (4), glucose (2), NaHCO1 (25), and polyethylene glycol 4000 (3 g/l) with 5 11Ci/l of 14C polyethylene glycol; PGE2 was added to the basic perfusate in a concentration of 0.2 mmol/l, the pH was adjusted to 7.0 with CO2 and the osmolality of the solution was 290 mosmol/kg.
A low (2 mmol/l) concentration of glucose was chosen, as luminal disappearance will reflect active transport and/or mucosal metabolism, and thus tissue viability. In all the experiments the concentration of glucose in the effluent ranged from 1-3 to 1.6 mmol/l. The dose of PGE2 was that which consistently induced secretion of water, as established in preliminary experiments. The mean percentage recovery of 14C polye,thylene glycol for all the perfusions was 100 (range 95-105). At the end of the three 10-minute collection periods the animal was killed by cardiac puncture.
In the cholera toxin experiments a blind loop was initially constructed from the proximal 15-20 cm of jejunum as described by Harries and Sladen,7 and cholera toxin (75 ,ug dissolved in 0.75 ml perfusate) was instilled into the loop, which was returned to the peritoneal cavity for two hours. The loop was then rinsed with perfusate and prepared for perfusion as in the PGE, experiments; the composition of the perfusate was identical with the basic perfusate used in the PGE, experiments. A second series of experiments with cholera toxin were carried out to study the effects of naloxone on the observed effects of loperamide on cholera toxin-induced secretion: naloxone was administered subcutaneously in two divided doses of 1-6 mg/kg at 4 and 45 hours as shown in the Figure. As with PGE2 the dose of naloxone was chosen on the basis of preliminary experiments, and the timing of its subcutaneous injection was based on studies in rats showing a half life of 30 to 40 minutes.8 9 As all the animals were in a steady-state with respect to net water, electrolyte, and glucose a'bsorption throughout the perfusion times, it was assumed that any effect of prolonged anaesthesia on absorption would be similar in control and test animals, and, therefore, comparisons are valid. In some experiments freeze-clamped, full-thickness biopsies of the perfused loops were obtained and stored at -700C for cyclic AMP (cAMP) assay. In other experiments mucosal scrapings were snap-frozen and stored at -700C for adenylate cyclase assay.
ANALYSES
The initial solutions and effluent were analysed for sodium and potassium by flame photometry Previous studies have shown a close temporal relationship between tissue cAMP concentrations, adenylate cyclase activity and the onset of secretion after exposure of the small intestine to cholera toxin, as well as to other agents which increase tissue cAMP, suggesting that the secretory process is intimately linked to the cAMP system. 14-10 Prostaglandin-induced secretion closely mimics that produced by cholera toxin in terms of tissue cAMP changes and electrical phenomena'4 17; there are differences, however, in the secretion'4 suggesting that the two secretagogues act via different or additional mechanisms.
In the present experiments loperamide inhibited cholera toxin induced secretion without any effect on the increased activity of adenylate cyclase or the tissue concentrations of cAMP. Moreover, naloxone which reduced the anti-secretory effects of loperamide also had no effect on tissue cAMP levels. These observations suggest that loperamide acts at a point distal to the increase in tissue cAMP. in modifying the secretory process. The finding that PGE2 inhibited glucose absorption is in agreement with previous reports, '8 19 and is in marked contrast to the lack of any effect of cholera toxin on glucose absorption, which is also in agreement with both our5 and other previous studies.'8 21 In addition, loperamide itself enhanced absorption of water, electrolytes, and glucose from an isotonic buffer containing glucose, and partially reversed the effects of PGE2 on water and electrolytes transport.
Although this study has not defined the precise mechanism(s) by which loperamide modifies cholera toxin and PGE2 induced secretion, the results suggest that the effects of the opiate analogue do not result from a direct effect on the cyclic AMP system. The data indicate that the antisecretory actions of loperamide occur via a naloxone sensitive mechanism, and as naloxone is an opiate antagonist, this in turn suggests that the effects of loperamide may be mediated by opiate receptors. However, only one concentration of the agonist and antagonist was investigated in the present study and additional studies directed towards demonstrating a dose-related effect of antagonist and agonist activity would add support to the notion that opiate receptors are involved.
